These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 11952043)
21. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study. Gao Y; Chang Q; Li Y; Zhang H; Hou Z; Zhang Z; Li Z; Li D BMC Ophthalmol; 2022 Feb; 22(1):66. PubMed ID: 35144579 [TBL] [Abstract][Full Text] [Related]
22. In situ expression of thyrotropin receptor in the extraocular muscles of patients with thyroid-associated ophthalmopathy. Chen J; Wei RL; He J; Ma XY Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):7-10. PubMed ID: 14724083 [TBL] [Abstract][Full Text] [Related]
23. T2 Relaxation Time in Extraocular Muscles of Patients with Mild Thyroid- Associated Ophthalmopathy: Comparing T2 Mapping With and Without Fat Suppression Using Different Measurement Methods. Li D; Guo X; Zeng J; Feng H; Zhu T; Li H Curr Med Imaging; 2024; 20():e15734056299907. PubMed ID: 38639286 [TBL] [Abstract][Full Text] [Related]
24. Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues. Hu H; Xu XQ; Chen L; Chen W; Wu Q; Chen HH; Zhu H; Shi HB; Wu FY Endocrine; 2020 Nov; 70(2):372-379. PubMed ID: 32504380 [TBL] [Abstract][Full Text] [Related]
25. Prognostic value of extraocular muscles for intraocular pressure in thyroid-associated ophthalmopathy patients. Tian H; Wang Y; Li J; Li H Quant Imaging Med Surg; 2023 Sep; 13(9):5727-5736. PubMed ID: 37711835 [TBL] [Abstract][Full Text] [Related]
26. Quantitative T1 mapping MRI for the assessment of extraocular muscle fibrosis in thyroid-associated ophthalmopathy. Ma R; Geng Y; Gan L; Peng Z; Cheng J; Guo J; Qian J Endocrine; 2022 Feb; 75(2):456-464. PubMed ID: 34549377 [TBL] [Abstract][Full Text] [Related]
27. Integrative transcriptomics and proteomic analysis of extraocular muscles from patients with thyroid-associated ophthalmopathy. Wu L; Zhang S; Li X; Yao J; Ling L; Huang X; Hu C; Zhang Y; Sun X; Qin B; Liu G; Zhao C Exp Eye Res; 2020 Apr; 193():107962. PubMed ID: 32057773 [TBL] [Abstract][Full Text] [Related]
29. Thyroid-Associated Ophthalmopathy: Preliminary Study Using T2 Mapping to Characterize Intraorbital Optic Nerve Changes Before Dysthyroid Optic Neuropathy. Hu H; Chen HH; Chen W; Wu Q; Chen L; Zhu H; Shi HB; Xu XQ; Wu FY Endocr Pract; 2021 Mar; 27(3):191-197. PubMed ID: 33630733 [TBL] [Abstract][Full Text] [Related]
30. Adhesion molecule expression in vivo on extraocular muscles (EOM) in thyroid-associated ophthalmopathy (TAO). Pappa A; Calder V; Fells P; Lightman S Clin Exp Immunol; 1997 May; 108(2):309-13. PubMed ID: 9158103 [TBL] [Abstract][Full Text] [Related]
31. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism. Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210 [TBL] [Abstract][Full Text] [Related]
32. Possible involvement of Fas-mediated apoptosis in eye muscle tissue from patients with thyroid-associated ophthalmopathy. Koga M; Hiromatsu Y; Jimi A; Inoue Y; Nonaka K Thyroid; 1998 Apr; 8(4):311-8. PubMed ID: 9588496 [TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy. Byun JS; Moon NJ; Lee JK Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):413-420. PubMed ID: 27838736 [TBL] [Abstract][Full Text] [Related]
34. Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy. Higashiyama T; Nishida Y; Morino K; Ugi S; Nishio Y; Maegawa H; Ohji M Jpn J Ophthalmol; 2015 Mar; 59(2):124-30. PubMed ID: 25448468 [TBL] [Abstract][Full Text] [Related]
36. Graves ophthalmopathy: MR imaging of the orbits. Hosten N; Sander B; Cordes M; Schubert CJ; Schörner W; Felix R Radiology; 1989 Sep; 172(3):759-62. PubMed ID: 2772184 [TBL] [Abstract][Full Text] [Related]
37. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence. Antoniazzi F; Zamboni G; Cerini R; Lauriola S; Dall'Agnola A; Tatò L J Pediatr; 2004 Apr; 144(4):527-31. PubMed ID: 15069405 [TBL] [Abstract][Full Text] [Related]
38. Graves ophthalmopathy: role of MR imaging in radiation therapy. Just M; Kahaly G; Higer HP; Rösler HP; Kutzner J; Beyer J; Thelen M Radiology; 1991 Apr; 179(1):187-90. PubMed ID: 2006276 [TBL] [Abstract][Full Text] [Related]
39. [Clinical Analysis of 2 170 Cases of Thyroid-Associated Ophthalmopathy Involving Extraocular Muscles]. Yang M; Du BX; Wang YJ; He WM Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):510-515. PubMed ID: 34018373 [TBL] [Abstract][Full Text] [Related]
40. [Management of Graves' ophthalmopathy by using orbital magnetic resonance imaging]. Hiromatsu Y; Eguchi H; Tani J Nihon Rinsho; 2012 Nov; 70(11):1932-7. PubMed ID: 23214064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]